Biosortia Microbiomics Company
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Founded Date:
2012-01-01
Last Funding Type:
Series C
Headquarters:
Dublin, Ohio, United States
Investors Number:
1.0
Technology:
['BioTech & HealthTech']
Employee Number:
11-50
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-10-01
Funding Status:
Seed
Investor Type:
Inquiries@Biosortia.com
Total Funding:
59000000